Home › Funds › Paradigm Biocapital Advisors LP › MANE

Paradigm Biocapital Advisors LP position in MANE

VERADERMICS INC · Health Care

Paradigm Biocapital Advisors LP reported holding 310,060 shares of MANE (VERADERMICS INC) in its Q3 2026 13F filing — a position valued at US$37.6M, representing 0.75% of its reported portfolio and ranking #20 among its reported holdings. Paradigm Biocapital Advisors LP has disclosed MANE holdings in 2 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)310.06K sh
Reported value held$37.59M
Portfolio Weight0.75%
First reportedQ1 2026
Last changeNew
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Paradigm Biocapital Advisors LP's MANE position evolved

Paradigm Biocapital Advisors LP first disclosed a stake in MANE in Q1 2026 at 525,000 shares (US$33.2M). The position peaked in Q3 2026 at 310,060 shares, worth US$37.6M. Across 2 filings, Paradigm Biocapital Advisors LP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 310,060 shares valued at US$37.6M.

Quarter by quarter

QuarterSharesValueChange
Q1 2026 525.00K $33.15M New
Q3 2026 310.06K $37.59M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MANE and 13F data

MANE (VERADERMICS INC) is a Health Care company. 150 other funds we track also report a position in MANE — the largest reported positions include MONTANOVA CAPITAL, LLC (US$512.5M), SR ONE CAPITAL MANAGEMENT, LP (US$295.3M), Deep Track Capital, LP (US$230.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MANE

All MANE fund holders →

FAQ

How long has Paradigm Biocapital Advisors LP held MANE?

Paradigm Biocapital Advisors LP has disclosed MANE holdings in 2 of the last 3 reported quarters, going back to Q1 2026.

What is Paradigm Biocapital Advisors LP's current position in MANE?

As of Q3 2026, Paradigm Biocapital Advisors LP holds 310.06K shares of MANE (VERADERMICS INC), valued at $37.59M, representing 0.75% of its reported portfolio and ranking #20.

Has Paradigm Biocapital Advisors LP been buying or selling MANE?

In the latest 13F filing (Q3 2026), Paradigm Biocapital Advisors LP newly opened its position in MANE. The position peaked in Q3 2026 at 310.06K shares.

Which other funds hold MANE?

Other major institutional holders of MANE include MONTANOVA CAPITAL, LLC, SR ONE CAPITAL MANAGEMENT, LP, Deep Track Capital, LP, among 150 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.